Kyung-Jin Jo Selected Research

Bone Resorption

3/2013

Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyung-Jin Jo Research Topics

Disease

4	Insulin Resistance 02/2019 - 09/2010
2	Obesity 02/2019 - 09/2010
1	Body Weight (Weight, Body) 02/2019
1	Muscular Atrophy (Muscle Atrophy) 12/2017
1	Type 2 Diabetes Mellitus (MODY) 03/2013
1	Bone Resorption 03/2013
1	Pneumonia (Pneumonitis) 05/2012
1	Sleep Deprivation 05/2012
1	Glucose Intolerance 09/2010

Drug/Important Bio-Agent (IBA)

3	Glucose (Dextrose)FDA LinkGeneric 02/2019 - 09/2010
2	Blood Glucose (Blood Sugar)IBA 02/2019 - 09/2010
2	Estrogens (Estrogen)FDA Link 10/2012 - 09/2010
1	LipidsIBA 02/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2019
1	Lipase (Acid Lipase)FDA Link 02/2019
1	Insulin Receptor Substrate ProteinsIBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	Protein Tyrosine PhosphatasesIBA 12/2017
1	AMP-Activated Protein KinasesIBA 12/2017
1	dihydrotanshinone IIBA 12/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2013
1	Exenatide (Byetta)FDA Link 03/2013
1	AntioxidantsIBA 05/2012
1	CytokinesIBA 05/2012
1	MelatoninIBA 05/2012
1	Insulin (Novolin)FDA Link 09/2010

Therapy/Procedure

1	Ovariectomy (Oophorectomy) 09/2010
1	Injections 09/2010